Jinpu Yu

机构：Tianjin Medical University Cancer Institute and Hospital · ORCID：0000-0002-5982-2266

发表论文 241 篇 · 总被引 5976 次 · h-index 41

代表论文

• A prospective study of neoadjuvant pembrolizumab plus chemotherapy for resectable esophageal squamous cell carcinoma: The Keystone-001 trial (2024 · Cancer Cell · 被引 53)
• Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors (2024 · Global Medical Genetics · 被引 15)
• Autophagy-Activating Nanoautophagosome-Tethering Compounds for Targeted Protein Degradation Specifically in Tumor Cells (2025 · ACS Macro Letters · 被引 11)
• A new perspective on targeting pulmonary arterial hypertension: Programmed cell death pathways (Autophagy, Pyroptosis, Ferroptosis) (2024 · Biomedicine & Pharmacotherapy · 被引 11)
• Optical Genome Mapping Reveals the Landscape of Structural Variations and Their Clinical Significance in HBOC-Related Breast Cancer (2024 · Frontiers in Bioscience-Landmark · 被引 6)
• Expert Consensus on the Diagnosis and Treatment of Malignant Mesothelioma of the Tunica Vaginalis Testis (2025 · iMetaMed · 被引 3)